Banerjee, R <br/><br/>
Sustained antiproliferative mechanisms by RB24, a targeted precursor of multiple inhibitors of epidermal growth factor receptor and a DNA alkylating agent in the A431 epidermal carcinoma of the vulva cell line.  [electronic resource] 

 -  British journal of cancer  Sep 2004 
 - 1066-73 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0007-0920 
<br/><br/><label>Standard No.: </label>10.1038/sj.bjc.6602098  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Alkylating Agents--pharmacology<br/>Antineoplastic Agents--pharmacology<br/>Carcinoma, Squamous Cell<br/>Cell Division--drug effects<br/>Cell Line, Tumor<br/>DNA Damage<br/>ErbB Receptors--antagonists & inhibitors<br/>Female<br/>Humans<br/>Phosphorylation<br/>Quinazolines--pharmacology<br/>Triazenes--pharmacology<br/>Vulvar Neoplasms